ERY-TAB
Active substance: erythromycin
TABLET, DELAYED RELEASE · ERYTHROMYCIN 333 mg/1
United StatesActive
Marketing holder: Arbor Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ERYTHROMYCIN · 333 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 41 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-296c-7a09-a154-9ab195d68c79,01a1208c-3238-7f36-8149-7ba0e79ab066,01a1208c-4d3e-7b22-a123-c8f17d84bb7f,01a1208c-6f44-7257-92b3-3a2931e1ea62,01a1208c-778f-752a-a5b9-a78b2f45bb0d;count=77 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 24338-124
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 24338-124 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 24338-124 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 24338-124 · Verified 2026-10-09 · open in source